Related Experiment Video
Updated: Feb 24, 2026

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
Alan K Okada1, Kazuki Teranishi1, Fleur Lobo1
1Department of Biochemistry and Molecular Biology, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California, 90033, USA.
Abstract:
Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate the cell's unfolded protein response via direct interactions with amyloidogenic proteins. Here, we explored the effects of the MDP-analog, humaninS14G (HNG), and the MDP, small humanin-like peptide 2 (SHLP2), on the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in type 2 diabetes mellitus (T2DM). Our thioflavin T fluorescence studies show that HNG inhibits IAPP misfolding at highly substoichiometric concentrations. Seeded fluorescence and co-sedimentation studies demonstrate MDPs block amyloid seeding and directly bind misfolded, seeding-capable IAPP species. Furthermore, our electron paramagnetic resonance spectroscopy and circular dichroism data indicate MDPs do not act by binding IAPP monomers. Taken together our results reveal a novel chaperone-like activity wherein these MDPs specifically target misfolded amyloid seeds to inhibit IAPP misfolding which, along with direct anti-apoptotic activity and beneficial metabolic effects, make HNG and SHLP2 exciting prospects as T2DM therapeutics. These data also suggest that other mitochondrial stress response factors within the MDP family may be amenable to development into therapeutics for protein-misfolding diseases.
Insights
Mitochondrial-derived peptides (MDPs) like humaninS14G and SHLP2 inhibit islet amyloid polypeptide (IAPP) misfolding by targeting toxic amyloid seeds. These findings suggest MDPs as potential therapeutics for type 2 diabetes mellitus (T2DM).
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Mitochondrial-derived peptides (MDPs) are stress response factors with protective roles in amyloid disease models.
- Their cytoprotective functions are often linked to anti-apoptotic activity, but their role in the unfolded protein response and direct interaction with amyloidogenic proteins is less understood.
- Islet amyloid polypeptide (IAPP) misfolding is a critical pathogenic event in type 2 diabetes mellitus (T2DM).
Purpose of the Study:
- To investigate the effects of the MDP analog humaninS14G (HNG) and the MDP small humanin-like peptide 2 (SHLP2) on IAPP misfolding.
- To determine if MDPs can inhibit IAPP misfolding and amyloid seeding.
- To elucidate the mechanism by which MDPs interact with IAPP.
Main Methods:
- Thioflavin T fluorescence assays to monitor IAPP misfolding.
- Seeded fluorescence and co-sedimentation studies to assess amyloid seeding and binding.
- Electron paramagnetic resonance spectroscopy and circular dichroism to analyze MDP-IAPP interactions.
Main Results:
- HNG inhibited IAPP misfolding at substoichiometric concentrations.
- MDPs effectively blocked IAPP amyloid seeding and directly bound to misfolded, seeding-capable IAPP species.
- MDPs do not bind to IAPP monomers, indicating a specific interaction with misfolded forms.
Conclusions:
- MDPs exhibit novel chaperone-like activity by specifically targeting misfolded IAPP seeds, thereby inhibiting IAPP misfolding.
- HNG and SHLP2, with their anti-apoptotic and potential metabolic benefits, are promising therapeutic candidates for T2DM.
- Other MDPs may also be developed as therapeutics for protein-misfolding diseases.
Related Concept Videos
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...

